CCK 2 binding peptides have been used in imaging and therapy (Fig. 2) [ 65– 67, 75].
MHC binding peptides have been shown to be disproportionately unglycosylated relative to the parent proteins and lysosomes are known to have aggressive enzymatic machinery to deglycosylate proteins.
Up to now, no specific binding peptides have been identified for borides in general, neither nanostructured nor bulk material, or more specifically nickel boride nanoparticles.
To overcome these difficulties, various chemical modifications of the integrin-binding peptides have been performed in order to enhance integrin binding affinity [ 29, 30].
Volunteers were selected according to HLA type, since T cell responses were measured by stimulating PBMC with a limited repertoire of HLA class I and II alleles for which strongly-binding peptides had been identified from the five antigens.
The universal pan allelic HLA DR binding epitope (PADRE) peptide has been used for the synthesis of constructs containing unglycosylated, Tn (Gal-NAcα- O-Ser/Thr), and TF (Galβ1-3GalNAcα- O-Ser/Thr) modified MUC1, showing induction of IgG against the three B-cell epitopes.
Control indirect ELISAs indicated that inoculation with α-peptide 1 or α/β-peptide 2 conjugated to bovine γ-globulin carrier protein induces the production of IgY antibodies capable of binding to the peptide antigen when that peptide has been conjugated to ovalbumin and immobilized.
At a structural level, the binding of RSC to histone tail peptides has been observed to result in a change in the conformation of the RSC complex (Skiniotis et al., 2007).
3) Similar combinatorial uses of multiple binding sites to bind diverse peptides have been shown and extensively characterized in other solenoid helical repeat protein systems such as the recognition diverse NLS peptides by the importin Transportin-1 or Karyopherin-beta2.
Several tests for antibodies binding to citrullinated peptides have been developed and some are in clinical use; however, they do not present the original antigen but rather rely on the cross-reaction of anti-citrullinated protein antibodies (ACPA).
